UPClytics
View all cases

UPC CFI 476/2024

Aug 14, 2024·EP4183412 Unitary patent · RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Case details
Status
Case Closed (Withdrawn)
Action
Revocation
Category
Main revocation action
Parties
Claimants
Representatives
Respondents
Representatives
Division
Milan CD
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
Language
English
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Patent revokedMedian days to first decision
All UPC37% (34/91)124
Milan CDLockedLocked
Judge Andrea PostiglioneLockedLocked
Judge Anna-Lena KleinLockedLocked
Judge Steen Wadskov-Hansen—Locked

At the UPC: Pfizer Group (31 cases)·GlaxoSmithKline Biologicals SA (20 cases)

This dispute contains 7 other proceedings

UPC CFI 468/2024·UPC APP 16306/2025·UPC APP 16366/2025·UPC APP 17607/2025·UPC APP 17784/2025 and 2 more

1 other defendants litigating the same or a related patent

UPC CFI 687/2024

Start a free trial to see how each one ended.

More cases: Milan CD·2024

Decisions
  • 2025-04-22
    Application RoP 265Public

    Summary: Milan Central Division allowed Pfizer's withdrawal of the revocation action and the counterclaim for revocation concerning GlaxoSmithKline's EP 4 183 412 (RSV vaccine patent), allowing GSK to withdraw its corresponding patent amendment application. Proceedings were declared closed. Each party bears its own costs. The request for 60% court fee reimbursement was allowed.

    Show the legal issues (3)
    • Withdrawal of revocation action under R.265 RoP
    • Withdrawal of patent amendment application
    • Court fee reimbursement
Document titleDatePublic
Case Closure Formal Check2025-04-28Not public
Outcome of the Order2025-04-22Not public
Outcome of the Order2025-04-22Not public
Order on request to withdraw2025-04-22Public
Template-Order2025-04-22Not public
Order on request to withdraw2025-04-22Public
Template-Order2025-04-22Not public
Receipt2025-04-11Not public
250410 GSK - Withdrawal of applications to amend2025-04-10Not public
Receipt2025-04-10Not public